search
Back to results

Transcranial Magnetic Stimulation to Improve Gesture Control (GestTMS)

Primary Purpose

Schizophrenia and Related Disorders

Status
Completed
Phase
Phase 1
Locations
Switzerland
Study Type
Interventional
Intervention
left IFG iTBS
right IPL cTBS
Placebo
Sponsored by
University of Bern
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenia and Related Disorders focused on measuring gesture, rTMS, nonverbal communication, schizophrenia, psychosis

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Right handed according to the Edinburgh Handedness Inventory
  • Ability and willingness to participate in the study
  • Ability to provide written informed consent
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Spent majority of childhood/adolescence in Switzerland
  • Patients: schizophrenia spectrum disorder according to Diagnostic and Statistical Manual version 5 (DSM-5)

Exclusion Criteria:

  • Women who are pregnant or breast feeding
  • Metal objects on or in the body (e.g. grenade splinter, cardiac pacemaker, vessel clips, metal prostheses, contraceptive coil, cochlear implants, hearing aid, tooth implant)
  • History of neurosurgery, any severe head wounds, history of neurologic disorders impacting gesture, e.g. Parkinson's disease, stroke, multiple sclerosis sclerosis and epilepsy, convulsion or seizure
  • History of any hearing problems or ringing in the ears.
  • Active drug addiction except nicotine
  • Controls: first-degree relatives with schizophrenia spectrum disorders

Sites / Locations

  • University Hospital of Psychiatry

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Placebo Comparator

Arm Label

left IFG iTBS

right IPL cTBS

placebo

Arm Description

intermittent theta burst stimulation over the left inferior frontal gyrus

continuous theta burst stimulation over the right inferior parietal cortex

Placebo TMS stimulation over the left inferior parietal cortex

Outcomes

Primary Outcome Measures

Test of Upper Limb Apraxia
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group
Test of Upper Limb Apraxia
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment
Test of Upper Limb Apraxia
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment
Test of Upper Limb Apraxia
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment

Secondary Outcome Measures

Coin rotation
Test of dexterity, 3 trials of 10s to rotate a .5 Swiss Francs (SFr) coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Coin rotation
Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Coin rotation
Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Coin rotation
Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

Full Information

First Posted
March 25, 2018
Last Updated
April 25, 2019
Sponsor
University of Bern
search

1. Study Identification

Unique Protocol Identification Number
NCT03483909
Brief Title
Transcranial Magnetic Stimulation to Improve Gesture Control
Acronym
GestTMS
Official Title
Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Gesture Control in Schizophrenia: A Randomised, Placebo-controlled, Double-blind Crossover Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
January 29, 2018 (Actual)
Primary Completion Date
April 1, 2019 (Actual)
Study Completion Date
April 23, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Bern

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The majority of schizophrenia patients is impaired in hand gesture performance, which contributes to poor functional outcome and poor communication skills. The left inferior frontal gyrus (IFG) and the left inferior parietal lobe (IPL) are key nodes of the gesture network, which is less active in patients with schizophrenia. Here, the investigators test single sessions of rTMS/TBS known to either enhance or inhibit local brain activity for app. 1 hour. The investigators aim to determine, which protocol may improve gesture performance in patients and healthy controls. This is a randomized, double-blind, cross-over, placebo-controlled single-center trial in 20 patients with schizophrenia spectrum disorders and 20 healthy controls. Gesture performance will be tested immediately after each TMS session, which are separated by 48 hours. Results of this study will inform larger interventional trials comparing 2 TMS protocols with repeated administration.
Detailed Description
Schizophrenia is associated with poor social functioning, which is perturbed by deficits in social interaction including nonverbal communication. The use of hand gestures is critical for nonverbal communication, but the majority of schizophrenia patients has severe gesture impairments. Today no intervention may ameliorate gesture impairments. Patients with gesture impairments have altered structure and function of the gesture network, particularly the left inferior frontal gyrus (IFG) and also the left inferior parietal lobe (IPL). Noninvasive brain stimulation techniques may alter local brain function. Repetitive transcranial magnetic stimulation (rTMS) and particularly theta burst stimulation (TBS) for a few mins is a very safe method to alter brain states locally for approximately 1 hour. Indeed, facilitatory stimulation of the left frontal cortex by transcranial direct current stimulation (tDCS) demonstrated improved gesture perception and interpretation in healthy subjects. In addition, inhibitory stimulation with continuous theta burst stimulation (cTBS) over left IFG may perturb gesture performance in healthy subjects. Thus, the investigators hypothesize that local changes of brain activity within the gesture network would change gesture performance. Particularly, facilitatory intermittent theta burst stimulation (iTBS) of the left IFG would improve gesture performance. The investigators will test single sessions of rTMS in healthy subjects and schizophrenia patients. If one of the protocols proves to have superior effects, this result will help to plan interventional trials targeting social interaction deficits in schizophrenia. The aim of the study is to determine the effect of one session of iTBS over the left IFG on gesture performance compared to cTBS over the right IPL (active comparator) and one placebo rTMS sessions. This is a randomized, double-blind, cross-over, placebo-controlled single-center trial in 20 patients with schizophrenia spectrum disorders and 20 healthy controls. After baseline assessment of gesture performance, participants will receive one rTMS protocol at each time point, immediately followed by assessments of gesture performance and dexterity. rTMS sessions will be separated by 48 hours. Gesture performance will be measured with video recorded Test of Upper Limb Apraxia, which is rated blindly according to a manual.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia and Related Disorders
Keywords
gesture, rTMS, nonverbal communication, schizophrenia, psychosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Crossover Assignment
Model Description
randomized, double-blind, cross-over trial of 3 rTMS protocols
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
participants, outcome assessors and raters are blinded. rTMS application is performed by an unblinded investigator
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
left IFG iTBS
Arm Type
Experimental
Arm Description
intermittent theta burst stimulation over the left inferior frontal gyrus
Arm Title
right IPL cTBS
Arm Type
Active Comparator
Arm Description
continuous theta burst stimulation over the right inferior parietal cortex
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
Placebo TMS stimulation over the left inferior parietal cortex
Intervention Type
Device
Intervention Name(s)
left IFG iTBS
Intervention Description
15 daily sessions of intermittent theta burst stimulation at 80% resting motor threshold, total duration of 190 s, localization using EEG 10/20 system at F3/F4
Intervention Type
Device
Intervention Name(s)
right IPL cTBS
Intervention Description
15 daily sessions of continuous theta burst stimulation at 100% resting motor threshold, total duration of 45 s, localization using EEG 10/20 system at F3/F4
Intervention Type
Device
Intervention Name(s)
Placebo
Intervention Description
rTMS with a placebo coil that looks identical and makes identical noises for 180 s, localization over left IPL
Primary Outcome Measure Information:
Title
Test of Upper Limb Apraxia
Description
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group
Time Frame
10 mins after baseline assessment
Title
Test of Upper Limb Apraxia
Description
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment
Time Frame
10 mins after left IFG iTBS
Title
Test of Upper Limb Apraxia
Description
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment
Time Frame
10 mins after right IPL cTBS
Title
Test of Upper Limb Apraxia
Description
Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment
Time Frame
10 min after placebo stimulation
Secondary Outcome Measure Information:
Title
Coin rotation
Description
Test of dexterity, 3 trials of 10s to rotate a .5 Swiss Francs (SFr) coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Time Frame
20 min after baseline assessment
Title
Coin rotation
Description
Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Time Frame
20 min after left IFG iTBS
Title
Coin rotation
Description
Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Time Frame
20 min after right IPL cTBS
Title
Coin rotation
Description
Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns
Time Frame
20 min after placebo stimulation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Right handed according to the Edinburgh Handedness Inventory Ability and willingness to participate in the study Ability to provide written informed consent Informed Consent as documented by signature (Appendix Informed Consent Form) Spent majority of childhood/adolescence in Switzerland Patients: schizophrenia spectrum disorder according to Diagnostic and Statistical Manual version 5 (DSM-5) Exclusion Criteria: Women who are pregnant or breast feeding Metal objects on or in the body (e.g. grenade splinter, cardiac pacemaker, vessel clips, metal prostheses, contraceptive coil, cochlear implants, hearing aid, tooth implant) History of neurosurgery, any severe head wounds, history of neurologic disorders impacting gesture, e.g. Parkinson's disease, stroke, multiple sclerosis sclerosis and epilepsy, convulsion or seizure History of any hearing problems or ringing in the ears. Active drug addiction except nicotine Controls: first-degree relatives with schizophrenia spectrum disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sebastian Walther, MD
Organizational Affiliation
University of Bern, University Hospital of Psychiatry
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Psychiatry
City
Bern
ZIP/Postal Code
3000
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The investigators do not plan to share the data, because they cannot anonymize the video data sufficiently

Learn more about this trial

Transcranial Magnetic Stimulation to Improve Gesture Control

We'll reach out to this number within 24 hrs